- Report
- January 2024
- 170 Pages
Global
€4533EUR$4,995USD£3,822GBP
- Report
- January 2024
- 120 Pages
United States
€3176EUR$3,500USD£2,678GBP
- Report
- December 2023
- 157 Pages
Global
€4533EUR$4,995USD£3,822GBP
- Report
- November 2023
- 190 Pages
Global
From €4492EUR$4,950USD£3,787GBP
- Report
- November 2023
- 110 Pages
Global
From €2677EUR$2,950USD£2,257GBP
- Report
- November 2023
- 109 Pages
Middle East, Africa
From €2677EUR$2,950USD£2,257GBP
- Report
- November 2023
- 107 Pages
From €2677EUR$2,950USD£2,257GBP
- Report
- November 2023
- 119 Pages
Asia Pacific
From €3131EUR$3,450USD£2,640GBP
- Report
- November 2023
- 122 Pages
Europe
From €3131EUR$3,450USD£2,640GBP
- Report
- November 2023
- 119 Pages
North America
From €2677EUR$2,950USD£2,257GBP
- Report
- October 2023
Global
From €5445EUR$6,000USD£4,590GBP
- Report
- August 2023
- 28 Pages
Global
€11117EUR$12,250USD£9,372GBP
- Report
- August 2023
- 115 Pages
Global
From €4084EUR$4,500USD£3,443GBP
- Report
- August 2023
- 220 Pages
Global
€4352EUR$4,795USD£3,669GBP
- Report
- July 2023
- 223 Pages
Global
From €4084EUR$4,500USD£3,443GBP
- Report
- July 2023
- 173 Pages
Global
From €4084EUR$4,500USD£3,443GBP
- Report
- June 2023
- 22 Pages
Global
€11117EUR$12,250USD£9,372GBP
- Report
- March 2023
- 26 Pages
Global
€11117EUR$12,250USD£9,372GBP
- Report
- October 2021
- 70 Pages
United States
From €692EUR$763USD£584GBP
€989EUR$1,090USD£834GBP
- Report
- April 2021
- 85 Pages
United States
From €825EUR$909USD£696GBP
€1179EUR$1,299USD£994GBP

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders.
Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists.
Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more